Holdings

Nomura Healthcare Fund

As of Jun 30, 2026, Nomura Healthcare Fund reported 92 positions worth US$692M. Largest: Ucb S.A., AbbVie Inc. and Eli Lilly and Company. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Ucb S.A.130KUS$39Mno changeJun 30, 2026
AbbVie Inc.125KUS$31.5Mno changeJun 30, 2026
Eli Lilly and Company26,000US$31.2Mno changeJun 30, 2026
Regeneron Pharmaceuticals, Inc.47,000US$29.3Mno changeJun 30, 2026
UnitedHealth Group Incorporated70,000US$29.1Mno changeJun 30, 2026
Pfizer, Inc.1.2MUS$28.8M+50,000Jun 30, 2026
Merck & Company, Inc.215KUS$27.6Mno changeJun 30, 2026
Gilead Sciences, Inc.210KUS$26.5Mno changeJun 30, 2026
AstraZeneca PLC131KUS$24.5Mno changeJun 30, 2026
Elevance Health, Inc.63,000US$24.4Mno changeJun 30, 2026